Business Description
OncoTherapy Science Inc
ISIN : JP3202150003
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.71 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -33.07 | |||||
Beneish M-Score | -3.14 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44.8 | |||||
3-Year EBITDA Growth Rate | 24.2 | |||||
3-Year EPS without NRI Growth Rate | 24.3 | |||||
3-Year FCF Growth Rate | 34.5 | |||||
3-Year Book Growth Rate | -45.1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.58 | |||||
9-Day RSI | 38.65 | |||||
14-Day RSI | 39.21 | |||||
6-1 Month Momentum % | -26.92 | |||||
12-1 Month Momentum % | -45.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.87 | |||||
Quick Ratio | 3.29 | |||||
Cash Ratio | 2.63 | |||||
Days Inventory | 54.08 | |||||
Days Sales Outstanding | 27.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -9.03 | |||||
Operating Margin % | -130.29 | |||||
Net Margin % | -132.35 | |||||
FCF Margin % | -88.8 | |||||
ROE % | -134.68 | |||||
ROA % | -94.22 | |||||
ROIC % | -571.94 | |||||
ROC (Joel Greenblatt) % | -3138.07 | |||||
ROCE % | -125.98 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.04 | |||||
PB Ratio | 5.97 | |||||
Price-to-Tangible-Book | 5.96 | |||||
EV-to-EBIT | -2.83 | |||||
EV-to-EBITDA | -2.83 | |||||
EV-to-Revenue | 3.68 | |||||
EV-to-FCF | -3.88 | |||||
Price-to-Median-PS-Value | 0.06 | |||||
Price-to-Net-Current-Asset-Value | 6.45 | |||||
Price-to-Net-Cash | 12.08 | |||||
Earnings Yield (Greenblatt) % | -35.4 | |||||
FCF Yield % | -20.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
OncoTherapy Science Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 901.22 | ||
EPS (TTM) (円) | -5.761 | ||
Beta | 0.84 | ||
Volatility % | 35.28 | ||
14-Day RSI | 39.21 | ||
14-Day ATR (円) | 1.421243 | ||
20-Day SMA (円) | 19.05 | ||
12-1 Month Momentum % | -45.71 | ||
52-Week Range (円) | 16 - 45 | ||
Shares Outstanding (Mil) | 217.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OncoTherapy Science Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OncoTherapy Science Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
OncoTherapy Science Inc Frequently Asked Questions
What is OncoTherapy Science Inc(TSE:4564)'s stock price today?
When is next earnings date of OncoTherapy Science Inc(TSE:4564)?
Does OncoTherapy Science Inc(TSE:4564) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |